Trump Media & Technology (DJT) had the highest return between December 27, 2023 and January 22, 2024 by a mid-cap US stock, returning 172.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Trump Media & Technology (DJT) | 12/27/2023 - 1/22/2024 | 172.57% |
Sezzle Inc Common Stock (SEZL) | 12/27/2023 - 1/22/2024 | 90.13% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 12/27/2023 - 1/22/2024 | 87.72% |
Dave (DAVE) | 12/27/2023 - 1/22/2024 | 81.1% |
Alvotech (ALVO) | 12/27/2023 - 1/22/2024 | 26.38% |
Sarepta Therapeutics (SRPT) | 12/27/2023 - 1/22/2024 | 25.17% |
ADMA Biologics (ADMA) | 12/27/2023 - 1/22/2024 | 21.33% |
Merus (MRUS) | 12/27/2023 - 1/22/2024 | 21.32% |
QXO (QXO) | 12/27/2023 - 1/22/2024 | 21.32% |
Soleno Therapeutics (SLNO) | 12/27/2023 - 1/22/2024 | 19.82% |
Oscar Health (OSCR) | 12/27/2023 - 1/22/2024 | 18.92% |
Viking Therapeutics (VKTX) | 12/27/2023 - 1/22/2024 | 18.28% |
Kemper (KMPR) | 12/27/2023 - 1/22/2024 | 17.71% |
Glaukos (GKOS) | 12/27/2023 - 1/22/2024 | 16.76% |
Vericel Corp Ord (VCEL) | 12/27/2023 - 1/22/2024 | 15.59% |
Axsome Therapeutics (AXSM) | 12/27/2023 - 1/22/2024 | 14.32% |
Abercrombie & Fitch (ANF) | 12/27/2023 - 1/22/2024 | 14.02% |
HealthEquity (HQY) | 12/27/2023 - 1/22/2024 | 13.74% |
Cytokinetics (CYTK) | 12/27/2023 - 1/22/2024 | 13.63% |
Grupo Aval (AVAL) | 12/27/2023 - 1/22/2024 | 13.48% |
Lazard (LAZ) | 12/27/2023 - 1/22/2024 | 13.46% |
Acuity Brands (AYI) | 12/27/2023 - 1/22/2024 | 13.31% |
Rush Street Interactive (RSI) | 12/27/2023 - 1/22/2024 | 13.26% |
Intapp (INTA) | 12/27/2023 - 1/22/2024 | 12.71% |
Turkcell Iletisim Hizmetleri AS (TKC) | 12/27/2023 - 1/22/2024 | 12.53% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
